Bonothyrk Protocol
Dosing & Research
Last Updated: September 4, 2026
Parathyroid function support, Calcium-phosphate homeostasis research, Bone-mineral balance studies, Endocrine aging models
Half-Life
Not Well Characterized
Administration
Oral
Frequency
Daily
How It Works
- Parathyroid function support
- Calcium-phosphate homeostasis research
- Bone-mineral balance studies
- Endocrine aging models
Dosing Structure
Dose
10–20 mg/day oral capsules
Frequency
Daily
Notes
Typically Administered As Defined Courses (10–20 Days) Repeated 1–2x Per Year, Rather Than Continuous Daily Dosing. Based On Khavinson Institute And Associated Russian Clinical Research.
Example Protocols
Dose: 10–20 mg/day oral capsules
Frequency: Daily
Duration: 1 Month
Off Period: Not listed
Find Research Grade Bonothyrk
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Typically administered as defined courses (10–20 days) repeated 1–2x per year, rather than continuous daily dosing.
•
Based on Khavinson Institute and associated Russian clinical research.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.